login
login
Image header Agence Europe
Europe Daily Bulletin No. 12805
EU RESPONSE TO COVID-19 / Health

EMA publishes its recommendations on administration of third dose of Pfizer/BioNTech and Moderna Covid-19 vaccines

On Monday 4 October, the European Medicines Agency (EMA) said that a third dose of the Covid-19 vaccines developed by Pfizer/BioNTech (Comirnaty) and Moderna (Spikevax) can be given to immunocompromised people at least 28 days after their second injection.

Studies have shown that the use of an extra dose of these vaccines increases the ability to produce antibodies in patients with weakened immune systems, according to the Agency.

It also stresses the importance of distinguishing between...

Contents

EXTERNAL ACTION
ECONOMY - FINANCE - BUSINESS
EU RESPONSE TO COVID-19
SECTORAL POLICIES
EUROPEAN PARLIAMENT PLENARY
FUNDAMENTAL RIGHTS - SOCIETAL ISSUES
COUNCIL OF EUROPE
NEWS BRIEFS